Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd | Sector: Pharmaceuticals | ISIN: INE312C01025

₹ 7.75 (-0.64%) icon

2 Jan, 2023, 3:58:41 PM

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/1/2023 3:58:41 PM

    ₹ 7.75 -0.05 -0.64
  • Open
  • ₹ 8
  • Prev. Close
  • ₹ 7.8
  • Turnover(Lac.)
  • ₹ 115
  • Day's High
  • ₹ 8.05
  • Day's Low
  • ₹ 7.75
  • 52 Week's High
  • ₹ 11.6
  • 52 Week's Low
  • ₹ 7.1
  • Book Value
  • ₹ 2.6
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 728.5
  • P/E
  • 45.76
  • EPS
  • 0.17
  • Divi. Yield
  • 0.35

Corporate Actions

02 Nov , 2022

12:00 AM

02 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 Aug , 2022

12:00 AM

AGM

Announcement date: 13 Aug , 2022

View Details

13 Aug , 2022

12:00 AM

Dividend

Dividend amount: 0.03
Announcement date: 13 Aug , 2022

View Details

01 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Aug , 2022

12:00 AM

28 Jun , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

10 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 Feb , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Feb , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Feb , 2022

12:00 AM

16 Aug , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
02 February , 2023 | 03:51 AM

PROMOTER - TOTAL50.57%

Indian: 50.57%

Foreign: 0%

NON-PROMOTER - TOTAL 49.43%

Institutions: 0.00%

Non-Institutions: 49.43%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more

Syncom Formulations (India) Ltd News and Update

Image not found
  • 11 hours ago |
  • 2:50 PM

Extending benefits of standard deduction to new tax regime for salaried class and pensioners.

Image not found
Image not found
Image not found
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Syncom Formulations (India) Ltd

  • Kedarmal Bankda

  • Chairman & Wholetime Director
  • Vijay Shankarlal Bankda

  • Managing Director
  • Vinod Kumar Kabra

  • Independent Director
  • Krishna Das Neema

  • Independent Director
  • Praveen Jindal

  • Independent Director
  • Rinki Bankda

  • Whole-time Director
  • Prachi Jain

  • Company Sec. & Compli. Officer
  • Ruchi Jindal

  • Addtnl Independent Director

Summary

Incorporated as a private limited company in 1988, Syncom Formulations (India) was converted into a public limited company in Jun.92. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations. Commercial production commenced in Apr.89. Promoters are Kedarmal Bankda, Vijay Kumar Bankda and Ajay Kumar Bankda.In addition to pharmaceutical formulations in the form of tablets, capsules, liquids and dry powders, the company also manufactures injectibles and ear/eye drops on a loan licence basis.In 1994, the company undertook an expansion programme of setting up a new plant for manufacturing pharmaceutical formulations at Pithampur, Madhya Pradesh. The project which was financed through a public issue made in Jan.94 was completed in 1995.During the year 1997-98, the Company has further diversified into Ethical Operations by introducing the range of prescription formulations.During the year 1998-99 there has been huge expansion of installed capacity and production base. Further the company plans introduction of products in the generic, OTC and Ethical Divisions. The export earnings have also registered a growth of more than 100%.During the year 1999-2000, the company and its associates have received export orders worth Rs.700.00 lacs against advance payment and hence better turnover is expected during the year. The company presently exports goods to Guine, Ghana, Kenya, Tanzania, Nigeria in Africa, Azberjan, Nepal and Srilanka in Asia. The... Read More


Reports by Syncom Formulations (India) Ltd


Reports by Syncom Formulations (India) Ltd